Ozari Health
Ozari identifies medical networks and plan-specific pharmacies for compounded GLP treatment. Its disclosures help, but pharmacy history, broad legality claims and wellness evidence need careful interpretation.
Review by Molly Ward, goal-guide writer · Updated October 2026
The short version
Use the named network and pharmacy details to verify the actual prescription. Ingredient biology, a branded trial or pharmacy licensing alone does not validate every customized preparation.
Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
Lowest listed: Glutathione injection, from $100/mo
Visit Ozari Health →Ozari LLC operates a remote prescription platform with separate medical providers and pharmacies. It offers compounded semaglutide and tirzepatide, alongside distinct NAD+, sermorelin and glutathione injection pathways. Those products have different evidence and monitoring considerations. The branded-drug trial illustrations are expressly separated from studies of Ozari’s compounded formulations.
What Ozari Health prescribes, by goal
Weight
- SemaglutideFDA-approved
- Injection (compounded)From $175/mo
- TirzepatideFDA-approved
- Injection (compounded)From $235/mo
The current product descriptions identify compounded subcutaneous injections and distinguish them from approved branded medicines. The broader FAQ makes sweeping legality and safety statements. Actual compounding conditions depend on the patient, preparation, pharmacy and applicable requirements; a general facility label does not settle every prescription.
Longevity
- NAD+Compounding conditions apply
- Injection (compounded)From $199/mo
- GlutathioneCompounding conditions apply
- Injection (compounded)From $100/mo
The wellness pages describe NAD+, sermorelin and glutathione injections with proposed benefits involving energy, recovery and body composition. Those marketing claims should not be read as proven outcomes for each dispensed preparation. NAD+ is a coenzyme. Confirm the proposed indication, evidence and monitoring before adding a separate wellness prescription.
Recovery
- SermorelinCompounding conditions apply
- Injection (compounded)From $159/mo
Sleep
- SermorelinCompounding conditions apply
- Injection (compounded)From $159/mo
Each “From” figure is the seller’s own starting price, in the unit the seller states. Where a required fee or a package length changes what one month costs, the smaller line under it is our arithmetic, not a figure the seller prints. Compounded preparations are not FDA-approved.
Who prescribes
A licensed clinician
The provider section names individual clinicians, including Sean Arora, MD, Shannon Arora, MD, and Michael Wasef, MD. It identifies Arora Health and Wasef Health roles. Other named professionals belong to its clinical content team rather than necessarily treating every patient. Confirm the practitioner assigned to the prescription and the relevant state authorization.
A questionnaire and remote clinician review precede the prescribing decision. A required live phone or video visit is not mentioned in that public process. The program describes ongoing access to the care team for follow-up and dose questions. Ask which contacts are medical assessments and how unexpected symptoms receive timely clinical review.
Are labs required?
Not mentioned
The public offer describes clinical assessment and continuing support without establishing a universal laboratory panel or included testing amount. Ask what the prescriber requires for the selected product and medical history. A separate wellness treatment should not automatically inherit the monitoring or service inclusions of a GLP plan.
Ready to start with Ozari Health?
Lowest listed price: Glutathione injection, from $100/mo. Confirm it on the seller’s own site.
What it claims, and what it cites
Hallandale is one named Select-plan pharmacy. FDA closed its historical 2020 warning in May 2022, then published separate June 2025 inspectional observations involving sterile practices. The later observations are not a final agency determination or a finding against Ozari. Confirm the actual dispensing assignment rather than assuming every patient receives medicine from that facility.
Other products and treatment claims
- An interchangeable pharmacy or formulation across plans
- One and Select use different formulation and pharmacy rules; a network list does not establish every patient’s dispensing assignment.
How it bills
Ozari One’s lower GLP figures require quarterly payment and differ from Select’s $175 semaglutide and $235 tirzepatide monthly options. Plan selection also changes formulation and pharmacy assignment. The general terms and newer cancellation explanations differ about commitment and notice. Obtain the selected invoice and controlling agreement rather than relying on the smallest headline.
For and against
- For: Individual clinicians and network roles identified
- For: Plan-specific pharmacy assignments published
- For: Compounded products distinguished from branded trial evidence
- For: Explicit routes for separate wellness preparations
- Against: Actual prescriber and dispenser still require confirmation
- Against: Broad legality and safety claims need qualification
- Against: Universal laboratory protocol not established
- Against: Public commitment and cancellation descriptions differ
The evidence behind what it sells
- Semaglutide Side Effects: What the Wegovy Trials and Label Recorded
- Glutathione Side Effects: What Injection, IV and Oral Studies Reported
- Sermorelin Side Effects: What the Trials and FDA Record Report
- Tirzepatide Side Effects: What the Zepbound Label and Trials Recorded
- NAD Side Effects: What Injection, IV and Oral Precursor Studies Reported
- Does Sermorelin Work? What the Human Studies Measured
Right for
A patient verifying the actual formulation, responsible practitioner and pharmacy through the service’s published network information.
Look elsewhere if
Someone treating a facility label, branded trial percentage or a wellness benefit list as proof about every compounded prescription.
Other sellers for weight
Enara Health
Also prescribes Semaglutide, Tirzepatide.
Arc-1
Also prescribes Semaglutide, Tirzepatide.
Livea
Also prescribes Semaglutide, Tirzepatide.
Ozari Health
Frequently asked questions
- Does every plan use the same pharmacy and formulation?
- No. The One and Select descriptions identify different formulation and pharmacy-assignment rules.
- Do the displayed branded trials directly test the dispensed compounds?
- No. The site expressly distinguishes those illustrations from evidence about its compounded preparations.
- Does the Hallandale record establish a finding against an Ozari patient’s shipment?
- No. It concerns a particular pharmacy history, and the actual dispensing assignment needs confirmation.
Sources
- FDA current conditions for compounded GLP products
- Current named clinical network and treatment distinctions
- Plan prices, formulations and pharmacy assignments
- Program questions and clinical access
- Legal operator and minimum-term wording
- Pharmacy-transmission cutoff and early-plan recalculation
- Hallandale plan assignment and exact facility identity
- FDA historical Hallandale warning closeout, May 3, 2022
- FDA Hallandale inspection observations, June 13, 2025
- Compounded NAD injection and monthly versus quarterly options
- Sermorelin injection offer and evidence limits
- Glutathione injection pathway
See what Ozari Health prescribes today
Ozari Health sets its own prices, plans and the states it serves. Check them before you start.